Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Apremilast did not work for treating severe alopecia areata.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

JAK inhibitors are effective for long-term management of alopecia areata.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

Gefitinib can cause hair loss without scarring.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Advanced dermoscopy techniques improve diagnosis and treatment monitoring for Kerion celsi but don't guarantee full hair regrowth.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Cystatin M/E helps in the final stages of hair and nail formation by controlling certain enzymes.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.